SYNERCID Side Effects

6970065-1 | Sepsis
on Aug 31, 2010 Male patient from JAPAN , weighting 123.5 lb, was diagnosed with sepsis (What is sepsis?), blood pressure abnormal and was treated with Synercid (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?). Synercid dosage: 8.9 Mg/kg, Tid. During the same period patient was treated with ZYVOX (1200 Mg, Qd) (View Zyvox Review and Zyvox Label ), FINIBAX (0.75 G, Qd) (View Finibax Review and Finibax Label ), OMEPRAL (20 Mg, Qd) (View Omepral Review and Omepral Label ), ADONA (0.5% 10 Ml, Qd) (View Adona Review and Adona Label ), PANTOL (100 Mg, Qd) (View Pantol Review and Pantol Label ), DOPAMINE HCL (0.3% Syringe 50 Mg, Qd) (View Dopamine Hcl Review and Dopamine Hcl Label ).

6963695-4 | Blood Bilirubin Increased, Cardiovascular Insufficiency, Catheter Site Haemorrhage, Gastrointestinal Haemorrhage
Patient was taking Synercid (View Usage). Patient had the following side effects: blood bilirubin increased, cardiovascular insufficiency, catheter site haemorrhage, gastrointestinal haemorrhage on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 125.0 lb, was diagnosed with staphylococcal sepsis, intervertebral discitis, staphylococcal infection (What is staphylococcal infection?) and. Synercid dosage: 750 Mg, Tid. During the same period patient was treated with VANCOMYCIN (750 Mg, Tiw) (View Vancomycin Review and Vancomycin Label ), RIFAMPIN (600 Mg, Bid) (View Rifampin Review and Rifampin Label ), EPOGEN (10000 U, Qt, Th + Sat After Hemodialysis) (View Epogen Review and Epogen Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), HYDROCORTISONE (50 Mcg, Q6h) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6764462-7 | Sepsis
Adverse event was reported on Jun 01, 2010 by a Male patient taking Synercid (View Usage) (Dosage: 500 Mg/kg, Tid) was diagnosed with sepsis (What is sepsis?), blood pressure abnormal and. Location: JAPAN , weighting 123.5 lb, After Synercid was administered, patient had the following side effects: sepsis (What is sepsis?). During the same period patient was treated with LINEZOLID (1200 Mg, Qd) (View Linezolid Review and Linezolid Label ), DORIPENEM (0.75 G, Qd) (View Doripenem Review and Doripenem Label ), OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), CARBAZOCHROME SODIUM SULFONATE (0.5% 10 Ml, Qd) (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), PANTHENOL (100 Mg, Qd) (View Panthenol Review and Panthenol Label ), DOPAMINE HYDROCHLORIDE (0.3% Stringe 50 Mg, Qd) (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ).

6609138-1 | Encephalopathy
on Feb 26, 2010 Male patient from UNITED STATES , 74 years of age, weighting 231.5 lb, was diagnosed with abscess (What is abscess?) and was treated with Synercid (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy. Synercid dosage: 500 Mg Q8 Iv. During the same period patient was treated with TELAVANCIN HYDROCHLORIDE (600 Mg Q48 Iv) (View Telavancin Hydrochloride Review and Telavancin Hydrochloride Label ).


6265966-6 | Infusion Site Exfoliation, Infusion Site Extravasation, Infusion Site Oedema, Infusion Site Pain, Infusion Site Reaction, Infusion Site Ulcer, Infusion Site Vesicles, Systemic Candida
on Jul 02, 2009 Male patient from UNITED STATES , 81 years of age, was diagnosed with enterococcal infection and was treated with Synercid (View Usage). Patient had the following side effects: infusion site exfoliation, infusion site extravasation, infusion site oedema, infusion site pain, infusion site reaction, infusion site ulcer, infusion site vesicles, systemic candida. Synercid dosage: 500 Mg, Qid. Patient was hospitalized.

6251728-2 | Infusion Site Exfoliation, Infusion Site Extravasation, Infusion Site Oedema, Infusion Site Pain, Infusion Site Ulcer, Infusion Site Vesicles, Systemic Candida
Patient was taking Synercid (View Usage). After Synercid was administered, patient had the following side effects: infusion site exfoliation, infusion site extravasation, infusion site oedema, infusion site pain, infusion site ulcer, infusion site vesicles, systemic candida on Jun 23, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, was diagnosed with enterococcal infection and. Synercid dosage: 500 Mg, Qid. Patient was hospitalized.

6050332-9 | Lymphoma, Platelet Count Decreased, Thrombocytopenia
Adverse event was reported on Jan 15, 2009 by a Female patient taking Synercid (View Usage) (Dosage: 7.5 Mg/kg, Tid) was diagnosed with sepsis (What is sepsis?), lymphoma (What is lymphoma?) and. Location: JAPAN , 18 years of age, Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?), platelet count decreased, thrombocytopenia. During the same period patient was treated with RITUXIMAB (400 Mg, Solution) (View Rituximab Review and Rituximab Label ), ENDOXAN /00021101/ (200 Mg Solution) (View Endoxan /00021101/ Review and Endoxan /00021101/ Label ), ONCOVIN (1.5 Mg Solution) (View Oncovin Review and Oncovin Label ).

5341587-4 | Myalgia
on May 29, 2007 Male patient from UNITED STATES , 42 years of age, was treated with Synercid (View Usage). Patient had the following side effects: myalgia. Synercid dosage: .

5210091-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased
on Feb 09, 2006 Female patient from UNITED STATES , 49 years of age, weighting 125.7 lb, was diagnosed with enterococcal infection and was treated with Synercid (View Usage). After Synercid was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased. Synercid dosage: 430 Mg, Qh8; Intravenous.

5154164-5 | Blood Bilirubin Increased, Jaundice
Patient was taking Synercid (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, jaundice (What is jaundice?) on Nov 16, 2006 from UNITED STATES Additional patient health information: Female patient , 59 years of age, was diagnosed with intestinal gangrene and. Synercid dosage: 750 Mg Q8 Iv. During the same period patient was treated with CARTIA XT (View Cartia Xt Review and Cartia Xt Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), INDOCIN (View Indocin Review and Indocin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

4920506-6 | Anaemia, Arthralgia, Dizziness, Fatigue, Haemoglobin Decreased, Malaise, Myalgia, Nausea, Pallor
Adverse event was reported on Feb 13, 2006 by a Female patient taking Synercid (View Usage) (Dosage: 750 Mg, Every 8 Hours) was diagnosed with osteomyelitis and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: anaemia, arthralgia, dizziness (What is dizziness?), fatigue, haemoglobin decreased, malaise, myalgia, nausea (What is nausea?), pallor. During the same period patient was treated with IMIPENEM (250 Mg, Every 6 Hours) (View Imipenem Review and Imipenem Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), DOCUSATE (DOCUSATE) (View Docusate (docusate) Review and Docusate (docusate) Label ).

4742894-6 | Alanine Aminotransferase Increased, Ammonia Increased, Anuria, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Urea Increased, Coagulation Factor V Level Decreased, Condition Aggravated
on Aug 02, 2005 Female patient from FRANCE , 81 years of age, was diagnosed with endocarditis (What is endocarditis?) and was treated with Synercid (View Usage). After Synercid was administered, patient had the following side effects: alanine aminotransferase increased, ammonia increased, anuria, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, coagulation factor v level decreased, condition aggravated. Synercid dosage: 1.5 G, Qd. During the same period patient was treated with TARGOCID (1.2 G, Qd) (View Targocid Review and Targocid Label ), EUPANTOL (40 Mg, Qd) (View Eupantol Review and Eupantol Label ), CANCIDAS (50 Mg, Qd) (View Cancidas Review and Cancidas Label ). Patient was hospitalized.

4677547-6 | Blood Bilirubin Increased, Hepatic Failure, Liver Function Test Abnormal
on May 27, 2005 Female patient from , 63 years of age, weighting 138.9 lb, was diagnosed with enterococcal infection and was treated with Synercid (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, hepatic failure, liver function test abnormal. Synercid dosage: 450 Mg Q8h Intravenous. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), AMPHOTERICIN B BLADDER WASHES (View Amphotericin B Bladder Washes Review and Amphotericin B Bladder Washes Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), CIPR (View Cipr Review and Cipr Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

4654516-3 | Labyrinthitis, Nystagmus, Pyrexia
Patient was taking Synercid (View Usage). Patient had the following side effects: labyrinthitis, nystagmus, pyrexia on May 04, 2005 from Additional patient health information: Male patient , 61 years of age, weighting 195.6 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Synercid dosage: 600 Mg Q8h Intravenou. During the same period patient was treated with NOVOLIN N (View Novolin N Review and Novolin N Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), COREG (View Coreg Review and Coreg Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), R INSULIN (View R Insulin Review and R Insulin Label ). Patient was hospitalized.

4623089-3 | Blood Bilirubin Increased, Liver Function Test Abnormal
Adverse event was reported on Mar 28, 2005 by a Female patient taking Synercid (View Usage) (Dosage: 450 Mg Every 8 Hours Intravenous) was diagnosed with enterococcal infection and. Location: , 63 years of age, weighting 130.0 lb, After Synercid was administered, patient had the following side effects: blood bilirubin increased, liver function test abnormal. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), SEPTRA (View Septra Review and Septra Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ).

4557334-X | Arthralgia, Dysstasia, Myalgia, Oedema Peripheral
on Jan 19, 2005 Female patient from , weighting 147.0 lb, was diagnosed with endocarditis staphylococcal and was treated with Synercid (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, dysstasia, myalgia, oedema peripheral. Synercid dosage: 500mg Q8h Intravenou. During the same period patient was treated with NAVALBINE (View Navalbine Review and Navalbine Label ), TAXOL (View Taxol Review and Taxol Label ), DECADRON (View Decadron Review and Decadron Label ), PREVACID (View Prevacid Review and Prevacid Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), INSULIN (View Insulin Review and Insulin Label ).